Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on July 1, 2026

Jul. 1, 2026

NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences

Indeterminate GlobeNewswire

Jul. 1, 2026

FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

Indeterminate GlobeNewswire

Jul. 1, 2026

Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director

Indeterminate GlobeNewswire

Jul. 1, 2026

Ocugen to Participate in Upcoming July Industry Conferences

Indeterminate GlobeNewswire

Jul. 1, 2026

Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences

Indeterminate GlobeNewswire

Jul. 1, 2026

iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

Indeterminate GlobeNewswire

Jul. 1, 2026

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

Indeterminate GlobeNewswire

Jul. 1, 2026

Harrow Announces Commercial Launch of BYOOVIZ® in the United States

Indeterminate GlobeNewswire

Jul. 1, 2026

Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics

Indeterminate GlobeNewswire

Jul. 1, 2026

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

Indeterminate GlobeNewswire

Jul. 1, 2026

AI Disruption to Transform $8.5 Billion Decentralized Clinical Trials Market as Investment Activity Surges

Indeterminate GlobeNewswire

Jul. 1, 2026

Urteste S.A. Receives U.S. Patent for the Panuri Test

Indeterminate GlobeNewswire

Jul. 1, 2026

Alvotech further strengthens liquidity by securing term loan facility of $75 million

Indeterminate GlobeNewswire

Jul. 1, 2026

Oxford-Harrington Rare Disease Centre Strengthens Rare Childhood Cancer Programme Through Appointment of New Little Princess Trust Professor of Paediatric Oncology

Indeterminate GlobeNewswire

Jul. 1, 2026

Press Release: Availability of the aide-mémoire for Q2 2026 results

Indeterminate GlobeNewswire

Jul. 1, 2026

Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire »

Indeterminate GlobeNewswire

Jul. 1, 2026

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

Indeterminate GlobeNewswire

Jul. 1, 2026

Nicox : Demande d’autorisation de mise sur le marché de NCX 470 soumise aux Etats-Unis par Kowa, avec un paiement d’étape de 3 millions d’euros associé

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire